Common Contracts
5 similar Facility Agreement contracts by Intersect ENT, Inc., Oncology Institute, Inc., ADC Therapeutics SA
EXECUTION VERSION US_153737865v8 FACILITY AGREEMENT dated as of August 9, 2022 by and among The Oncology Institute, Inc., as the Borrower, the other Loan Parties party hereto from time to time, the Lenders and DEERFIELD PARTNERS, L.P., as agent for...Facility Agreement • August 10th, 2022 • Oncology Institute, Inc. • Services-offices & clinics of doctors of medicine • New York
EXECUTION VERSION US_153737865v8 FACILITY AGREEMENT dated as of August 9, 2022 by and among The Oncology Institute, Inc., as the Borrower, the other Loan Parties party hereto from time to time, the Lenders and DEERFIELD PARTNERS, L.P., as agent for...Facility Agreement • August 10th, 2022 • Oncology Institute, Inc. • Services-offices & clinics of doctors of medicine • New York
FACILITY AGREEMENT dated as of September 25, 2021 by and among INTERSECT ENT, INC., as the Borrower, the other Loan Parties party hereto from time to time, and Medtronic, Inc., as the LenderFacility Agreement • September 27th, 2021 • Intersect ENT, Inc. • Surgical & medical instruments & apparatus • New York
This FACILITY AGREEMENT (this “Agreement”), dated as of September 25, 2021 is entered into by and among INTERSECT ENT, INC., a Delaware corporation (the “Borrower”), the other Loan Parties (as defined below) party hereto from time to time, Medtronic, Inc., a Minnesota corporation (the “Lender” and, together with the Borrower and the other Loan Parties party hereto, the “Parties”).
FACILITY AGREEMENT dated as of July 22, 2021 by and among INTERSECT ENT, INC., as the Borrower, the other Loan Parties party hereto from time to time, the Lenders and DEERFIELD PARTNERS, L.P., as agent for itself and the Secured PartiesFacility Agreement • July 22nd, 2021 • Intersect ENT, Inc. • Surgical & medical instruments & apparatus • New York
This FACILITY AGREEMENT (this “Agreement”), dated as of July 22, 2021, is entered into by and among INTERSECT ENT, INC., a Delaware corporation (the “Borrower”), the other Loan Parties (as defined below) party hereto from time to time, the lenders set forth on the signature page of this Agreement (together with their successors and permitted assigns, the “Lenders”), DEERFIELD PARTNERS, L.P., as agent for itself and the other Secured Parties (in such capacity, together with its successors and assigns in such capacity, “Agent,” and, together with the Lenders, the Borrower and the other Loan Parties party hereto, the “Parties”).
FACILITY AGREEMENT dated as of April 24, 2020 by and among ADC THERAPEUTICS SA, as the Borrower, the other Loan Parties party hereto from time to time, the Lenders and DEERFIELD PARTNERS, L.P., as agent for itself and the Secured PartiesFacility Agreement • April 27th, 2020 • ADC Therapeutics SA • Pharmaceutical preparations • New York
This FACILITY AGREEMENT (this “Agreement”), dated as of April 24, 2020, is entered into by and among ADC THERAPEUTICS SA, a Swiss société anonyme (the “Borrower”), the other Loan Parties (as defined below) party hereto from time to time, the lenders set forth on the signature page of this Agreement (together with their successors and permitted assigns, the “Lenders”), DEERFIELD PARTNERS, L.P., a Delaware limited partnership, as agent for itself and the other Secured Parties (in such capacity, together with its successors and assigns in such capacity, “Agent,” and, together with the Lenders, the Borrower and the other Loan Parties party hereto, the “Parties”).
